Loading clinical trials...
Loading clinical trials...
A Phase I, Open-Label, Two Centre Study to Evaluate Dichloroacetate(DCA) in Advanced Pulmonary Arterial Hypertension.
Conditions
Interventions
Dichloroacetate Sodium
Dichloroacetate Sodium
+1 more
Locations
2
Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Imperial College
London, United Kingdom
Start Date
March 1, 2010
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2013
Last Updated
June 3, 2014
Lead Sponsor
University of Alberta
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions